These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 27223595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Maintenance agonist treatments for opiate dependent pregnant women.
    Minozzi S, Amato L, Vecchi S, Davoli M.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006318. PubMed ID: 18425946
    [Abstract] [Full Text] [Related]

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 7. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M.
    Addiction; 2018 Jul 01; 113(7):1286-1294. PubMed ID: 29443414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M, Battin M, Walker E, Brown M, Abdelwahab M, Ma'ayeh M, Rood KM.
    J Matern Fetal Neonatal Med; 2022 Dec 01; 35(26):10481-10486. PubMed ID: 36202398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic opioid use during pregnancy: maternal and fetal implications.
    Stanhope TJ, Gill LA, Rose C.
    Clin Perinatol; 2013 Sep 01; 40(3):337-50. PubMed ID: 23972743
    [Abstract] [Full Text] [Related]

  • 16. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
    Suarez EA, Huybrechts KF, Straub L, Hernández-Díaz S, Jones HE, Connery HS, Davis JM, Gray KJ, Lester B, Terplan M, Mogun H, Bateman BT.
    N Engl J Med; 2022 Dec 01; 387(22):2033-2044. PubMed ID: 36449419
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC, Johnston AM, Crocker AM, Heil SH.
    J Addict Med; 2015 Dec 01; 9(2):81-6. PubMed ID: 25622120
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
    Robin AM, Hersh AR, John C, Caughey AB.
    J Matern Fetal Neonatal Med; 2022 Dec 01; 35(25):4918-4926. PubMed ID: 33455473
    [Abstract] [Full Text] [Related]

  • 20. Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation.
    Mactier H, Shipton D, Dryden C, Tappin DM.
    Addiction; 2014 Mar 01; 109(3):482-8. PubMed ID: 24321028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.